pl

Zarejestruj się
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów.

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Strona główna・Stock List・Rocket Pharmaceuticals Inc
Search

Rocket Pharmaceuticals Inc

Closed

Sector Healthcare

18.45

Strong Buy

Price update 6 wrz 2024, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

18.45

Max

18.64

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+162.72 upside

Dividends

By Dow Jones

Next Earnings

1 lis 2024

News Sentiment

By Acuity

50%

50%

114 / 365 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

18.54 / 19.1 Support & Resistance

Rocket Pharmaceuticals Inc Chart

Related News

28 cze 2024, 14:25 UTC

Major Market Movers

Rocket Pharmaceuticals Shares Slide After FDA Rejects Kresladi

DJ

Read

12 wrz 2023, 21:13 UTC

Major Market Movers

Rocket Pharmaceuticals Stock Surges 34% on FDA Alignment for Danon Disease Treatment

DJ

Read

Peer Comparison

Price change

Rocket Pharmaceuticals Inc Forecast

Price Target

By TipRanks

162.72% upside

12 Months Forecast

Average 48.63 USD  162.72%

High 65 USD

Low 34 USD

Based on 12 Wall Street analysts offering 12 month price targets forRocket Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

11

Buy

1

Hold

0

Sell

Based on 12 analysts giving stock ratings to Rocket Pharmaceuticals Inc - Dist in the past 3 months.

Technical Score

By Trading Central

18.54 / 19.1Support & Resistance

Short Term

Weak Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

There is one bearish event.

Sentiment

By Acuity

114 / 365 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Other stocks from the sector

LLY

Eli Lilly and Co.

902.74

↓-0.9%

UNH

UnitedHealth Group Inc

596.8

↑ +0.31%

NVO

Novo Nordisk A-S

131.05

↑ +0.18%

JNJ

Johnson and Johnson

164.37

↓-0.29%

ABBV

AbbVie Inc

193.18

↑ +0.34%